ISR refers to research sponsored and conducted by qualified investigators. All ISR grant proposals should align with one of our research areas of interest.
ISRs are clinical trials, registries or other real world evidence studies, health outcomes research studies, or pre-clinical research studies usually involving the Company’s drug(s) where a third party investigator independently proposes the study, serves as the sponsor-investigator, and assumes all responsibility for the conduct of the study. The Company may provide drug, drug powder, and/or financial support. These studies can involve investigational or marketed products.
Melinta welcomes rezafungin proposals in the following research areas of interest:
Patient-Centered Research in Long-Term Antifungal (AF) Treatment
- Impact of once weekly antifungal therapy on patient Quality of life (QoL) in outpatient setting compared to once daily echinocandins
- Patient preferences and awareness of treatment options for candidemia/invasive candidiasis
- Compliance with monitoring requirements and adherence challenges with daily AF treatment
Real-World Evidence (RWE) on Rezafungin in Transition of Care
- Optimization of antifungal therapy during hospital discharge; utilization of rezafungin in transition from inpatient to outpatient therapy
- Impact of rezafungin on hospital length of stay (LoS) and readmission rates
- Long-term clinical outcomes associated with rezafungin
Prophylaxis and Treatment Strategies in Critical Care Patients
- Assess the clinical value of rezafungin for prophylaxis and/or treatment of C/IC in the intensive care setting of care
Addressing Unmet Needs in Antifungal Prophylaxis
Please use the form below to request a research grant. Ensure all pertinent fields are filled in or checked, and type of support you are requesting (commercial product, active pharmaceutical ingredient, funding, or a combination). Submit the completed form along with all other required documents to grants@melinta.com.
Post Approval Research & Development Grant Form
